SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19?

European Heart Journal

20 March 2020

Organised by:

Read full article

Abstract

Abstract

Contributors

Gabriela M Kuster

Gabriela M Kuster

Author

University Hospital Basel Basel , Switzerland

Otmar Pfister

Otmar Pfister

Author

Thilo Burkard

Thilo Burkard

Author

Qian Zhou

Qian Zhou

Author

University Hospital Basel Basel , Switzerland

Raphael Twerenbold

Raphael Twerenbold

Author

Philip Haaf

Philip Haaf

Author

Andreas F Widmer

Andreas F Widmer

Author

Stefan Osswald

Stefan Osswald

Author

University of Basel Basel , Switzerland

You may be interested in

Congress Presentation

Dynamics of indicators of central hemodynamics and arterial wall rigidity during the background of combination therapy with amlodipine/ valsartan in patients with arterial hypertension

Congress Session

Challenges in hypertension management

ESC TV Today

Episode 7: Coronary spasm - Sex differences in heart failure

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources